Distinct clinical subtypes of genetic frontotemporal dementia identified using disease progression modelling
Brain Communications · 31.10.2026 · 8 (6)
DOI: 10.1093/braincomms/fcag392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Communications, online erschienen am 15.10.2026. Verfasst von Kiran Samra und 36 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London WC1N 3AR, UK. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Research UK, Alzheimer's Society, Brain Research UK, The Wolfson Foundation.
Themen: Demenz
Abstract (Originalsprache)
Understanding the order in which symptoms occur in genetic frontotemporal dementia (FTD) may provide valuable insights into disease progression. Here we use a methodology called Ordinal Subtype and Stage Inference (SuStaIn) in the GENetic FTD Initiative (GENFI) cohort to estimate a probable order in which symptoms occur and identify different subtypes based on the pattern of symptom progression within the main genetic FTD mutation groups. A total of 968 participants were included in the cross-sectional study: 280 C9orf72, 242 GRN and 101 MAPT mutation carriers, and 345 mutation-negative controls. A total of 379 participants underwent longitudinal analysis: 162 C9orf72, 146 GRN and 71 MAPT mutation carriers. The standardized GENFI clinical assessment provided severity scores for all FTD-relevant symptoms ranging from 0, where symptoms are absent, to 3, where symptoms are severe. Ordinal SuStaIn was run in each mutation group to generate symptom progression profiles for mutation carriers from each group. In the C9orf72 cohort, Ordinal SuStaIn identified three subtypes: subtype 1 with early behavioural and cognitive deficits, subtype 2 with impaired speech and swallowing and subtype 3 with limb impairment. In the GRN cohort, SuStaIn identified two subtypes: subtype 1 with behavioural and cognitive deficits as well as limb motor involvement, and subtype 2 with early language impairment. The MAPT cohort was best described as a single subtype with a combination of cognitive (mainly semantic) and behavioural impairment with parkinsonism. SuStaIn stage significantly correlated with clinical severity scores for all the cohorts. The subtypes were somewhat longitudinally consistent, with a trend towards increased SuStaIn stage in each subtype over time. Identifying within-genotype data-driven subtypes of FTD is a novel approach for untangling the heterogeneity of this disorder, in turn drawing us closer to individualized care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London WC1N 3AR, UK.
- Department of Neurology, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands.
- Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut D'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, 08036 Barcelona, Spain.
- Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, Quebec City, QC G1J 1Z4, Canada.
- Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Bioclinicum, Karolinska Institutet, 171 64 Solna, Sweden.
- Unit for Hereditary Dementias, Theme Inflammation and Aging, Karolinska University Hospital, 171 64 Solna, Sweden.
ORCID-Profile: Kiran Samra, Arabella Bouzigues, William J Scotton, Lize C Jiskoot, Harro Seelaar, Raquel Sanchez-Valle, Caroline Graff, Rik Vandenberghe, Alexander Gerhard, Johannes Levin, Maxime Bertoux, Simon Ducharme, Christopher R Butler, Elizabeth C Finger, James B Rowe, Matthis Synofzik, Barbara Borroni, Neil P Oxtoby, Alexandra L Young
Förderung
- Alzheimer's Research UK
- Alzheimer's Society, Brain Research UK
- The Wolfson Foundation
- National Institute for Health Research Queen Square Dementia Biomedical Research Unit
- University College London Hospitals Biomedical Research Centre
- Leonard Wolfson Experimental Neurology Centre Clinical Research Facility
- UK Dementia Research Institute
- UK Dementia Research Institute Ltd
Zitieren
APA
Samra, K., Bouzigues, A., Foster, P. H., Ferry-Bolder, E., Scotton, W. J., van Swieten, J. C., Jiskoot, L. C., Seelaar, H., Sanchez-Valle, R., Laforce, R., Graff, C., Galimberti, D., Masellis, M., Tartaglia, M. C., Vandenberghe, R., de Mendonça, A., Tiraboschi, P., Santana, I., Gerhard, A., …, & GENFI (2026). Distinct clinical subtypes of genetic frontotemporal dementia identified using disease progression modelling. Brain Communications, 8(6). https://doi.org/10.1093/braincomms/fcag392
Vancouver
Samra K, Bouzigues A, Foster PH, Ferry-Bolder E, Scotton WJ, van Swieten JC, et al. Distinct clinical subtypes of genetic frontotemporal dementia identified using disease progression modelling. Brain Communications. 2026;8(6). doi:10.1093/braincomms/fcag392
BibTeX
@article{Samra2026,
author = {Samra, Kiran and Bouzigues, Arabella and Foster, Phoebe H and Ferry-Bolder, Eve and Scotton, William J and van Swieten, John C and Jiskoot, Lize C and Seelaar, Harro and Sanchez-Valle, Raquel and Laforce, Robert and Graff, Caroline and Galimberti, Daniela and Masellis, Mario and Tartaglia, Maria Carmela and Vandenberghe, Rik and de Mendonça, Alexandre and Tiraboschi, Pietro and Santana, Isabel and Gerhard, Alexander and Levin, Johannes and Sorbi, Sandro and Otto, Markus and Lebouvier, Thibaud and Bertoux, Maxime and Ducharme, Simon and Butler, Christopher R and Le Ber, Isabelle and Finger, Elizabeth C and Rowe, James B and Synofzik, Matthis and Moreno, Fermin and Borroni, Barbara and Oxtoby, Neil P and Russell, Lucy L and Rohrer, Jonathan D and Young, Alexandra L and GENFI, GENFI},
title = {Distinct clinical subtypes of genetic frontotemporal dementia identified using disease progression modelling},
journal = {Brain Communications},
year = {2026},
volume = {8},
number = {6},
doi = {10.1093/braincomms/fcag392}
}
EUVIMED